Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on May 13, 2017 12:22am

143 Views

Post# 26240169

RE:RE:RE:Is anybody following the hemophilia news this wk?

European hemophilia collaboration is unique . They take patients endothelial cells with hemophilia ...correct the gene defect and reintroduce them via Sva pouch back into the patient. So patients own cells are that produce factor 8 are reintroduced to cure hemophilia. So with this treatment no issues with immunosuppressive or encapsulated cells. Quite remarkable gene therapy. Don't know where they are with this European collaboration .

Bullboard Posts

Eminent acquires promising Nevada gold project